Product Information
RIVASTIGMINE 3 MG CAPSULE is a generic product labeled by Chartwell RX LLC, priced at $0.1666 per EA under NDC 62135090160. Its NADAC has been published 159 times since Jun 14, 2023.
Strength
3 mg/1
Manufacturer
Chartwell RX LLCNDC
62135090160
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
RIVASTIGMINE TARTRATEApproval Type
Generic (ANDA)
FDA Application
ANDA207797On Market Since
9/28/2017
Pharmacological Classes
Price Statistics
The NADAC for RIVASTIGMINE 3 MG CAPSULE has been published 159 times since Jun 14, 2023, and over the history we have for it it has declined 32.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1666 per EA |
|---|---|
| All-time high | $0.2454 (Jun 14, 2023) |
| All-time low | $0.1451 (Jul 17, 2024) |
| 52-week high | $0.2053 |
| 52-week low | $0.1578 |
| Median price | $0.1813 |
| Average price | $0.1877 |
| Largest weekly change | +26.4% (Nov 22, 2023) |
| Weeks tracked | 159 |
| Tracking since | Jun 14, 2023 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of RIVASTIGMINE 3 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for RIVASTIGMINE 3 MG CAPSULE, manufactured by Chartwell RX LLC, is $0.1666 per EA (NDC 62135090160), effective Jun 24, 2026.
How has the price of RIVASTIGMINE 3 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for RIVASTIGMINE 3 MG CAPSULE has declined 32.1%. It has been tracked across 159 weekly CMS publications since Jun 14, 2023.
What are the highest and lowest recorded NADAC prices for RIVASTIGMINE 3 MG CAPSULE?
Since Jun 14, 2023, the NADAC for RIVASTIGMINE 3 MG CAPSULE has ranged from a low of $0.1451 (Jul 17, 2024) to a high of $0.2454 (Jun 14, 2023), with a median of $0.1813 per EA.
Are there cheaper alternatives to RIVASTIGMINE 3 MG CAPSULE?
5 NADAC-published products share the same active ingredient, strength, and dosage form as RIVASTIGMINE 3 MG CAPSULE, but none are currently priced below it.
Who manufactures RIVASTIGMINE 3 MG CAPSULE?
RIVASTIGMINE 3 MG CAPSULE (NDC 62135090160) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification